Risk of ischemic stroke associated with DOAC discontinuation on patients with non-valvular atrial fibrillation

被引：0
|
作者：
Tlvaro Thomsen, Tobias [1 ]
Mesa Guadalupe, Jorge
Cea Soriano, Lucia [2 ]
Huerta, Consuelo [3 ]
De Burgos, Airam [4 ]
机构：
[1] Univ Complutense Madrid, Madrid, Spain
[2] Univ Complutense Madrid, Fac Med, Dept Publ Hlth & Child Hlth, Madrid, Spain
[3] Univ Complutense Madrid, Dept Publ Hlth, Fac Med, Madrid, Spain
[4] Spanish Agcy Med & Med Devices AEMPS, Div Pharmacoepidemiol & Pharmacovigilance, BIFAP, Madrid, Spain
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2022年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
179
引用
收藏
页码：75 / 75
页数：1
相关论文
共 50 条
  • [41] Neutrophil/lymphocyte ratio is associated with thromboembolic stroke in patients with non-valvular atrial fibrillation
    Ertas, Gokhan
    Sonmez, Osman
    Turfan, Murat
    Kul, Seref
    Erdogan, Ercan
    Tasal, Abdurrahman
    Bacaksiz, Ahmet
    Vatankulu, Mehmet Akif
    Altintas, Ozge
    Uyarel, Huseyin
    Goktekin, Omer
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2013, 324 (1-2) : 49 - 52
  • [42] Edoxaban for reducing the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation
    Dzeshka, Mikhail S.
    Lip, Gregory Y. H.
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (17) : 2661 - 2678
  • [43] INR optimization based on stroke risk factors in patients with non-valvular atrial fibrillation
    Jee Eun Chung
    Yoo Ri Choi
    Jong Mi Seong
    Hyen O La
    Hye Sun Gwak
    International Journal of Clinical Pharmacy, 2015, 37 : 1038 - 1046
  • [44] Predictors of warfarin discontinuation or switching among non-valvular atrial fibrillation patients
    Lip, G. Y. H.
    Keshishian, A.
    Li, X.
    Lee, T. C.
    Mardekian, J.
    Posner, N.
    Luo, X.
    EUROPEAN HEART JOURNAL, 2017, 38 : 774 - 775
  • [45] Association of left atrial size with ischemic and bleeding risk scores in patients with non-valvular atrial fibrillation
    Enriquez-Rodriguez, E.
    Borrego-Bernabe, L.
    Espejo Paeres, A. C.
    Rueda-Linarez, A. C.
    Jimenez-Martin, M.
    Alcantar Fernandez, A. C.
    Perez-Villacastin, J.
    Macaya, C.
    Perez De Isla, L.
    EUROPEAN HEART JOURNAL, 2018, 39 : 457 - 457
  • [46] Factors associated with elevated brain natriuretic peptide level in acute ischemic stroke patients with non-valvular atrial fibrillation
    Maruyama, K.
    Shiga, T.
    Ishizuka, K.
    Hoshino, T.
    Iijima, M.
    Uchiyama, S.
    Kitagawa, K.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 89 - 89
  • [47] THE DOSE OF DIRECT ORAL ANTICOAGULANTS AND STROKE SEVERITY IN PATIENTS WITH ACUTE ISCHEMIC STROKE AND NON-VALVULAR ATRIAL FIBRILLATION
    Kato, Y.
    Hayashi, T.
    Tanahashi, N.
    Takao, M.
    INTERNATIONAL JOURNAL OF STROKE, 2018, 13 : 135 - 135
  • [48] RIVAROXABAN IN PREVENTION OF STROKE IN ELDERLY PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
    Yavelov, I. S.
    KARDIOLOGIYA, 2019, 59 (12) : 4 - 11
  • [49] Optimising stroke prevention in non-valvular atrial fibrillation
    Ederhy, Stephane
    Cohen, Ariel
    EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (15) : 2079 - 2094
  • [50] CAUSES OF STROKE IN PATIENTS WITH NON-VALVULAR ATRIAL-FIBRILLATION (NVAF)
    BOGOUSSLAVSKY, J
    VANMELLE, G
    REGLI, F
    KAPPENBERGER, L
    STROKE, 1990, 21 (01) : 174 - 174
12345